Company Overview
Sb Drug Discovery Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Tuesday 08 October 2002, so this is a well established company. Sb Drug Discovery Limited has been in business for 23 years and 5 months. The accounts status is full and the accounts are next due on Wednesday 31 December 2025.
Registered Address

Telford Pavilion Block H, Todd Campus, West Of Scotland Science Park, Glasgow, G20 0XA
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameSB DRUG DISCOVERY LIMITED
Company NumberSC237873
Registered Office AddressTelford Pavilion Block H, Todd Campus
 West Of Scotland Science Park
 G20 0XA
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date08/10/2002
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryFULL
Returns Next Due Date28/01/2017
Returns Last Made Up Date31/12/2015
Previous Company NameChanged Date
SCOTTISH BIOMEDICAL LIMITED08 Jan 2013
Directors & Members
Show Resigned
Simon Hirst - Director
(British, 62 years old, born April 1964)
Appointed 16 December 2022
 Active
Louisa Jordison - Director
(British, 48 years old, born October 1978)
Appointed 16 December 2022
 Active
Jonathan Williams - Director
(British, 63 years old, born February 1963)
Appointed 16 December 2022
 Active
Secretaries
Show Resigned
Other Company Directorships
Simon Hirst
AGHOCO 1566 (BIDCO) LIMITED
AGHOCO 1578 (MIDCO) LIMITED
AGHOCO 1579 (TOPCO) LIMITED
EVERGREEN HOLDCO 1 LIMITED
EVERGREEN HOLDCO 2 LIMITED
EVERGREEN HOLDCO 3 LIMITED
FGHJ LIMITED
PEAK PROTEINS LTD.
RENASCI LIMITED
SPARK BIDCO LIMITED
SPARK MIDCO 2 LIMITED
SPARK MIDCO LIMITED
SPARK TOPCO LIMITED
SYGIL GROUP LIMITED
SYGIL RESEARCH (CYSTIC FIBROSIS) LIMITED
SYGIL RESEARCH LIMITED
SYGNATURE DISCOVERY LIMITED
SYGNATURE DISCOVERY TRUSTEE COMPANY LIMITED
XENOGESIS LIMITED
Louisa Jordison
AGHOCO 1566 (BIDCO) LIMITED
AGHOCO 1578 (MIDCO) LIMITED
AGHOCO 1579 (TOPCO) LIMITED
EVERGREEN HOLDCO 1 LIMITED
EVERGREEN HOLDCO 3 LIMITED
FGHJ LIMITED
PEAK PROTEINS LTD.
RENASCI LIMITED
SPARK BIDCO LIMITED
SPARK MIDCO 2 LIMITED
SPARK MIDCO LIMITED
SPARK PIKCO LIMITED
SPARK TOPCO LIMITED
SYGNATURE DISCOVERY LIMITED
XENOGESIS LIMITED
Jonathan Williams
AGHOCO 1566 (BIDCO) LIMITED
AGHOCO 1578 (MIDCO) LIMITED
AGHOCO 1579 (TOPCO) LIMITED
EVERGREEN HOLDCO 1 LIMITED
EVERGREEN HOLDCO 2 LIMITED
EVERGREEN HOLDCO 3 LIMITED
FGHJ LIMITED
PEAK PROTEINS LTD.
RENASCI LIMITED
SPARK BIDCO LIMITED
SPARK MIDCO 2 LIMITED
SPARK MIDCO LIMITED
SYGIL GROUP LIMITED
SYGIL RESEARCH (CYSTIC FIBROSIS) LIMITED
SYGNATURE DISCOVERY LIMITED
XENOGESIS LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Balance Sheet
Fixed Assets 810,561 810,561 463,798
Current Assets 2,943,963 2,943,963 2,388,564
Creditors Due Within One Year 1,611,215 1,611,215 1,050,215
Working Cap 1,332,748 1,332,748 1,338,349
Total Assets Less Current Liabilities 2,143,309 2,143,309 1,802,147
Long-term Liabilities 2,137,929 2,137,929 1,796,767
Net Assets 5,380 5,380 5,380
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 5,380 5,380 5,380
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Tangible Fixed Assets - - -
Fixed Assets 21.6% 21.6% 16.3%
Stocks Inventory - - -
Debtors 34.8% 34.8% 28.0%
Cash Bank In Hand 29.5% 29.5% 37.6%
Current Assets 78.4% 78.4% 83.7%
Creditors Due Within One Year 42.9% 42.9% 36.8%
Net Current Assets Liabilities 35.5% 35.5% 46.9%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 0.1% 0.1% 0.2%
Capital Employed - - -
Total Assets Less Current Liabilities 57.1% 57.1% 63.2%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Liquidity Ratio 1.8 1.8 2.3
Solvency Ratio 1.0 1.0 1.0
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 3
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 2
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Assets 3,754,524 3,754,524 2,852,362
Debt 3,749,144 3,749,144 2,846,982
Net Assets/Debt 5,380 5,380 5,380

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around G20 0XA
PATIENTS DIRECT LTD.
Suite 2/1 & Suite 3/1, Mccafferty House 99 Firhill Road, Glasgow, G20 0XA
CURIA (SCOTLAND) LIMITED
TODD CAMPUS, WEST OF SCOTLAND SCIENCE PARK, ACRE ROAD, GLASGOW, G20 0XA
ANACAIL LIMITED
C/O Wri Associates Ltd Third Floor, Turnberry House, 175 West George Street, Glasgow, G20 0XA
MEMORYCLINIC.COM LIMITED
20 Barns Street, Ayr, G20 0XA
QNOSTICS LIMITED
BLOCK 1 TODD CAMPUS, WEST OF SCOTLAND SCIENCE PARK, GLASGOW, G20 0XA
NEUROCLIN LIMITED
EXCEL HOUSE, 1 RENSHAW PLACE, MOTHERWELL, G20 0XA
COHERENT SCOTLAND LIMITED
TODD CAMPUS WEST OF SCOTLAND SCIENCE PARK, MARYHILL ROAD, GLASGOW, G20 0XA
SARTORIUS STEDIM BIOOUTSOURCE LIMITED
1 TECHNOLOGY TERRACE ACRE ROAD, TODD CAMPUS, WEST OF SCOTLAND SCIENCE PARK, GLASGOW, LANARKSHIRE, G20 0XA
ALBA ULTRASOUND LIMITED
UNIT 1, BLOCK 3, TODD CAMPUS, WEST OF SCOTLAND SCIENCE PARK, GLASGOW, G20 0XA
COMMUNITY PHARMACOLOGY SERVICES LIMITED
Suite 2/1 & Suite 3/1, Mccafferty House 99 Firhill Road, Glasgow, G20 0XA
Document Filings
Confirmation statement made on 31 December 2025 with no updates
Confirmation statement made on 31 December 2024 with no updates
Registered office address changed from Telford Pavilion, Block H Todd Campus, West of Scotland Science Park, Maryhi Glasgow G20 0XA to Telford Pavilion Block H, Todd Campus West of Scotland Science Park Glasgow G20 0XA on 5 December 2024
Termination of appointment of Paul Overton as a director on 20 May 2024
Director's details changed for Mrs Louisa Elizabeth Jordison on 31 July 2023
Confirmation statement made on 31 December 2023 with no updates
Registration of charge SC2378730003, created on 15 September 2023
Confirmation statement made on 31 December 2022 with no updates
Memorandum and Articles of Association
Resolutions
Appointment of Mr Paul Overton as a director on 16 December 2022
Termination of appointment of Eric Macdonald Smith as a director on 16 December 2022
Termination of appointment of David Dalrymple as a director on 16 December 2022
Termination of appointment of Ian Mcphee as a director on 16 December 2022
Appointment of Mr Jonathan Williams as a director on 16 December 2022
Termination of appointment of David Dalrymple as a secretary on 16 December 2022
Appointment of Mrs Louisa Jordison as a director on 16 December 2022
Appointment of Mr Simon Hirst as a director on 16 December 2022
Satisfaction of charge SC2378730002 in full
Annual return made up to 8 October 2008 with full list of shareholders
Annual return made up to 8 October 2007 with full list of shareholders
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free